To prevent overheating, U.S. power plants use as much water as the nations farms, 133 billion gallons a day. That puts an enormous strain on the water supply. But two University of Cincinnati professors have invented a way to cool things down that doesn't use any water. It uses air.

At least a dozen bio-tech companies plan to make the main chemicals in marijuana synthetically, according to the MIT Technology Review .

As experts try to get to the bottom of what's ailing bees, some beekeepers are using sensors to monitor the hives and uncover data that could help the species survive.

Researchers at Rice University, the University of Washington and others have created a working blood vessel network on a 3D printer that could eventually be part of a human lung or liver. But they stress it is only one step towards building organs that have very complex structures.

You could ride in a flying car as early as 2023 as long as you have the nerve and the money. Uber appears to be leading the pack of about a dozen developers. Research is also happening in Greater Cincinnati. UC students are designing their own model and hope to win $1 million in a competition.

Staff Sergeant Timothy Brown is getting used to his new handcycling voice-activated shifting device developed by University of Dayton senior engineering majors. The triple amputee must simply say "up" or "down" for the bike to shift.

NASA administrator Jim Bridenstein wants to move up the timetable for an astronaut landing on Mars to 2033. He told a House subcommittee April 3, "We need to learn how to live and work in another world." Part of the plan may include transporting and manufacturing complex drugs on Mars.

Concrete is becoming greener thanks to an innovative idea from Canada. The technology injects carbon dioxide into concrete and the mineralization process makes the concrete more durable while also reducing its carbon footprint.

A promising new cancer drug developed at Cincinnati Children's Hospital Medical Center and manufactured by Bexion Pharmaceuticals in Covington will soon be tested on children. BXQ-350 is already showing signs it's working on adults who have brain and gastrointestinal tumors.

A promising clinical trial co-sponsored by Cincinnati Children's Hospital Medical Center is underway at Hoxworth Blood Center for bone marrow transplant patients. It uses their own blood to fight infection before their immune system is able to.